Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Arthritis in Psoriasis Patients on Efalizumab
NCT00510536Phase 4Completed
- Sponsor
- Probity Medical Research
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of efalizumab in plaque psoriasis, sponsored by Probity Medical Research. Started Jul 2007; status: completed.
02
Drugs
efalizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00510536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510536.